India to Belgium: Albendazole Export Trade Route
India has recorded 230 verified shipments of Albendazole exported to Belgium, representing a combined trade value of $4.0M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $17.6K USD. The leading Indian exporter is GRACURE PHARMACEUTICALS LIMITED, which accounts for 60% of total export value with 125 shipments worth $2.4M USD. On the buying side, NA is the largest importer in Belgium with $3.6M USD in purchases. The top 3 suppliers — GRACURE PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED , MEDOPHARM — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belgium Albendazole corridor is one of India's established pharmaceutical export routes, with 230 shipments documented worth a combined $4.0M USD. The route is dominated by GRACURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $17.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #18 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Belgium include NA, EXPHAR SANIVELLES SUD ZONE II THINES, MSF SUPPLY ASBL and 16 others. NA is the single largest importer with 138 shipments valued at $3.6M USD.
